Design and synthesis of new stabilized combi-triazenes for targeting solid tumors expressing the epidermal growth factor receptor (EGFR) or its closest homologue HER2

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Growth Factor Receptor ◽

Design And Synthesis ◽

Faculty Opinions recommendation of Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14346.471799 ◽

2006 ◽

Author(s):

Jeffrey Evans

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Growth Factor Receptor ◽

Advanced Solid Tumors ◽

Irreversible Inhibitor ◽

Design and Synthesis of Novel Schiff Base-Benzothiazole Hybrids as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors

Anti-Cancer Agents in Medicinal Chemistry ◽

10.2174/1871520615666151007160115 ◽

2016 ◽

Vol 16 (6) ◽

pp. 722-739 ◽

Cited By ~ 7

Author(s):

Meenakshi Singh ◽

Sudhir Kumar Singh ◽

Bhushan Thakur ◽

Pritha Ray ◽

Sushil K. Singh

Keyword(s):

Schiff Base ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Egfr Inhibitors ◽

Design And Synthesis ◽

Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors

mAbs ◽

10.4161/mabs.3.1.14021 ◽

2011 ◽

Vol 3 (1) ◽

pp. 67-75 ◽

Cited By ~ 12

Author(s):

Chong Wang ◽

Xiaohui He ◽

Bo Zhou ◽

Jing Li ◽

Bohua Li ◽

...

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Phase 1 ◽

Growth Factor Receptor ◽

Phase 1 Study ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody

Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor

Human Antibodies ◽

10.3233/hab-140278 ◽

2015 ◽

Vol 23 (1-2) ◽

pp. 13-20 ◽

Cited By ~ 6

Author(s):

Behzad Baradaran ◽

Jafar Majidi ◽

Safar Farajnia ◽

Jaleh Barar ◽

Yadollah Omidi

Keyword(s):

Monoclonal Antibody ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Growth Factor Receptor ◽

Design and Synthesis of a Series of Novel Bisquinazoline Glycosides as Epidermal Growth Factor Receptor Inhibitors

Chemical Biology & Drug Design ◽

10.1111/j.1747-0285.2011.01209.x ◽

2011 ◽

Vol 78 (6) ◽

pp. 1006-1013 ◽

Cited By ~ 3

Author(s):

Shaopeng Chen ◽

Xiaowei Zhang ◽

Junlei Wang ◽

Shengbiao Wan ◽

Meiyu Geng ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Design And Synthesis ◽

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

The Oncologist ◽

10.1634/theoncologist.2016-0051 ◽

2016 ◽

Vol 21 (12) ◽

pp. 1483-1491 ◽

Cited By ~ 35

Author(s):

Ralf‐Dieter Hofheinz ◽

Gaël Deplanque ◽

Yoshito Komatsu ◽

Yoshimitsu Kobayashi ◽

Janja Ocvirk ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Growth Factor Receptor ◽

Skin Reactions ◽

Follicular Toxic Effects of Chimeric Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Used to Treat Human Solid Tumors

Archives of Dermatology ◽

10.1001/archderm.138.1.129 ◽

2002 ◽

Vol 138 (1) ◽

pp. 129-131 ◽

Cited By ~ 65

Author(s):

A. Kimyai-Asadi

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Growth Factor Receptor ◽

Toxic Effects ◽

Receptor Antibody ◽

Human Solid Tumors ◽

A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3162 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3162-3162 ◽

Cited By ~ 3

Author(s):

I. B. Vergote ◽

Y. Humblet ◽

E. van Cutsem ◽

S. van Belle ◽

J. Kerger ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Solid Tumors ◽

Phase Ii ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Multicenter Phase ◽

Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold

Journal of Medicinal Chemistry ◽

10.1021/jm2008634 ◽

2011 ◽

Vol 54 (23) ◽

pp. 8030-8050 ◽

Cited By ~ 89

Author(s):

Tomoyasu Ishikawa ◽

Masaki Seto ◽

Hiroshi Banno ◽

Youichi Kawakita ◽

Mami Oorui ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Design And Synthesis ◽

Dual Inhibitors ◽

Results of a phase I trial of the humanized anti epidermal growth factor receptor (EGFr) monoclonal antibody emd 72000 in patients with EGFr expressing solid tumors

European Journal of Cancer ◽

10.1016/s0959-8049(02)80814-0 ◽

2002 ◽

Vol 38 ◽

pp. S53

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Solid Tumors ◽

Phase I Trial ◽

Growth Factor Receptor ◽